Clinical Trial Detail

NCT ID NCT03448718
Title Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Matthew Galsky
Indications

transitional cell carcinoma

Therapies

Olaparib

Age Groups: senior adult

Additional content available in CKB BOOST